purpose make world smarter happier richer founded motley fool financial service company dedicated making world smarter happier richer motley fool reach million people every month premium investing solution free guidance market analysis foolcom toprated podcasts nonprofit motley fool foundation purpose make world smarter happier richer founded motley fool financial service company dedicated making world smarter happier richer motley fool reach million people every month premium investing solution free guidance market analysis foolcom toprated podcasts nonprofit motley fool foundation isrg earnings call period ending march image source motley fool intuitive surgical isrg q earnings callapr pm etcontents prepared remark question answer call participant prepared remark operatorthank everyone standing welcome intuitive q earnings release call time participant listenonly mode operator instruction reminder today call recorded turn call host head investor relation intuitive surgical brian king please go aheadbrian king head investor relation good afternoon welcome intuitives first quarter earnings conference call today gary guthart ceo jamie samath cfo begin would like inform comment mentioned today call may deemed contain forwardlooking statement actual result may differ materially expressed implied result certain risk uncertainty risk uncertainty described detail security exchange commission filing including recent annual report form k fiscal year ended december subsequent filing sec filing found website sec website investor cautioned place undue reliance forwardlooking statement please note conference call available audio replay website intuitivecom event section investor relation pagetodays press release supplementary financial data table posted website today format consist providing highlight first quarter result described press release announced earlier today followed questionandanswer session gary present quarter business operational highlight jamie provide review financial result discus procedure clinical highlight provide updated financial outlook finally host questionandanswer session turn gary gary guthart chief executive officer thank joining u today first quarter solid one intuitive core measure business remain healthy including solid procedure growth capital placement furthermore team delivered important milestone across several part intuitive ecosystem including launching nextgeneration multiport platform da vinci launching da vinci sp platform europe improving supply constraint ion catheter regional challenge existed quarter describe today taken together remain enthusiastic opportunity work nearterm pressure focusing control starting first procedure experienced solid growth quarter compared strong q result elevated patient volume return patient post pandemic q procedure performance led broad growth general surgery united state procedure beyond urology outside united state globally cholecystectomy colon resection foregut procedure led way regional performance included strength china germany united kingdom japan saw moderation growth urology reach higher level penetration q benefited return patient backlog korea growth lower expectation primarily due physician strike country began february continued turning capital placed da vinci system quarter multiport system compared multiport system q sp placement quarter versus system year ago ion placement quarter versus year ago capital placement solid united state global distribution market germany placement china appear impacted delayed tender apparent increase provincial preference domestic robotic competition saw placement weakness uk financial pressure nh constrained access capital system utilization defined procedure per installed system per quarter grew globally year year multiport platform lower last quarter historical trend result strong placement year multiport clinical installed base grew customer addressed covidrelated backlog newer platform utilization grew sp ion quarter utilization important indicator customer health reflection customer driving value system turning finance revenue growth quarter reflects solid procedure performance capital placement average system selling price declined modestly due regional product mix product margin within expectation reflecting higher mix newer platform operating expense came slightly plan resulting pro forma operating profit growth jamie take finance greater detail later call quarter made good progress new platform march received fda clearance nextgeneration multiport platform da vinci within quarter placed eight da vinci system surgeon completed first case engage customer activation da vinci customer noting appreciating improved precision improved imaging improved efficiency surgeon staff improved ergonomics exploring potential force feedback early surgeon excited test hypothesis procedural clinical learning value digital analytical capability da vinci also drawing positive review parallel customer support working hard optimize supply chain manufacturing capability da vinci component remain measured rollout stabilize supply respond customer input turning ion team made meaningful progress resolving supply challenge catheter ion vision probe although work still remains done earlier month fda reviewed set design production change cleared increase ion catheter life five life eight life alleviating supply constraint improving economics u customer also march received nmpa clearance ion china special review process innovative medical device nmpa clearance first step toward commercialization china believe ion play important role helping address significant burden lung cancer country turning sp received ce mark europe broad set indication quarter placed eight system first case europe performed april encouraged early customer interest sp closing priority follows first support measured launch da vinci new platform region second focused supporting surgeon adoption focused procedure third focused improving product margin quality finally focused improving productivity function benefit global scale turn time jamie take finance greater detailjamie samath chief financial officer good afternoon describe highlight performance nongaap pro forma basis also summarize gaap performance later prepared remark reconciliation pro forma gaap result posted website q da vinci procedure grew installed base system grew system average system utilization increased lower recent trend strength procedure growth utilization q last year reflected significant benefit treatment patient backlog u procedure grew driven broad growth general surgery bariatrics procedure growth u continued moderate flat year year ous procedure grew reflecting strong growth general surgery thoracic procedure brian provide additional detail clinical performance later call turning capital placed system first quarter compared system q last year excluding trading transaction net new system placement grew system u placed system q including eight da vinci five placement compared system placed q last year given constrained supply da vinci system placement may choppy year customer interested da vinci decide whether acquire fourthgeneration system upgrade rate wait adequate supply outside u placed system q compared system last year current quarter system placement included europe japan china compared europe japan china q last year placement uk expectation lower q last year reallocation nh capital funding help address industrial action nh placement china continue reflect impact domestic robotic competition delayed tender due broader central government focus systematic governance across sector including healthcare first quarter revenue billion increase last year constant currency basis revenue growth additional revenue statistic trend follows leasing represented q placement compared q last year given customer preference usagebased model u launch da vinci continue expect proportion system placed lease arrangement grow time q system average selling price million compared million last year system asp negatively impacted regional platform mix lower pricing china partially offset lower tradeins recognized million lease buyout revenue first quarter compared million last quarter million last year da vinci instrument accessory revenue per procedure approximately flat last year compared last quarter sequential decline ia per procedure primarily result procedure mix u given strong growth cholecystectomy moderation growth bariatrics also seen larger idns u look operational efficiency reducing inventory turning ion approximately ion procedure first quarter increase compared last year since launching ion platform cumulative basis procedure performed q placed ion system compared q last quarter q result reflected partial recovery last quarter catheter supply improved team continued work stabilizing supply catheter vision probe q result included four ion system placement uk following european clearance last year installed base ion system increased year year system operating lease arrangement system placed quarter sp system including eight system europe reflecting clearance early quarter first quarter sp procedure growth healthy growth korea u early stage growth japan u quarter completed k submission thoracic indication made continued regulatory progress toward colorectal submission enrolled additional patient ide nipplesparing mastectomy sp installed base grew yearago quarter system moving rest pl pro forma gross margin first quarter compared first quarter last quarter sequential reduction pro forma gross margin primarily reflects higher fixed cost including depreciation expense expanded manufacturing capacity higher cost associated launch da vinci manufacturing business unit team made progress quarter activity improve gross margin medium term remains area key focus u first quarter pro forma operating expense increased compared last year slightly lower expectation due timing certain expense pro forma operating expense percentage revenue basis point lower q last year reflecting planned leverage enabling function partially offset increased rd fund innovation future growth pro forma income million q higher million prior quarter primarily due higher interest income pro forma effective tax rate first quarter consistent expectation first quarter pro forma net income million per share compared million per share first quarter last year summarize gaap result gaap net income million per share first quarter compared gaap net income million per share first quarter first quarter gaap tax expense benefit million reflecting excess tax benefit associated employee equity plan million adjustment pro forma gaap net income outlined quantified website include excess tax benefit associated employee equity plan employee stockbased compensation amortization intangible litigation charge gain loss strategic investment ended quarter cash investment billion flat end last year sequential change cash included cash generated operating activity offset capital expenditure million net impact employee equity plan million would like turn brianbrian king head investor relation thank jamie overall first quarter procedure growth year year compared first quarter last quarter u first quarter procedure growth year year compared first quarter last quarter first quarter growth led procedure within general surgery strength cholecystectomy colon resection foregut procedure growth bariatrics procedure continued moderate flat year year outside u first quarter procedure volume grew compared first quarter last quarter procedure volume growth led procedure beyond urology strength colon resection hysterectomy lung resection procedure europe first quarter growth continued led general surgery gynecology procedure category germany uk procedure performance led region experiencing strong growth colon rectal resection hysterectomy procedure asia growth first quarter led china strong procedure performance urology gynecology procedure yearoveryear procedure growth country benefited comparison period procedure beginning recover covid first quarter japan experienced moderation growth urology overall procedure growth healthy strength general surgery procedure colon rectal resection gynecology procedure effective june five additional procedure reimbursement japan two existing rectal resection procedure receiving increase reimbursement equivalency laparoscopic surgery opportunity procedure relatively modest continues support adoption minimally invasive robotic surgery across growing set procedure turning clinical side business quarter call highlight certain recently published study deem notable however gain complete understanding body evidence encourage stakeholder thoroughly review extensive detail scientific study published year first quarter year dr jae hwan choi team university south florida tampa florida published metaanalysis randomized controlled trial describing outcome roboticassisted abdominopelvic surgery journal surgical endoscopy analysis included review publication published april included patient randomized controlled study covered variety abdominopelvic surgical procedure including antireflux gastrointestinal colorectal urologic hernia repair gynecologic procedure author compared roboticassisted outcome open laparoscopic procedure compared open approach roboticassisted procedure lower rate postoperative complication lower risk postoperative complication across procedure well le estimated blood loss mean difference milliliter furthermore length stay average day shorter roboticassisted procedure relative laparoscopic approach rate conversion open robotic assisted group approximately half rate laparoscopic approach length stay also shorter roboticassisted procedure interestingly author also reported analysis impact surgeon experience comparing inexperienced versus experienced surgeon found experienced roboticassisted surgeon lower risk intraoperative complication significantly le risk experienced group compared laparoscopic group well lower risk conversion open experienced surgeon relative laparoscopic group comparable operative time compared laparoscopy experienced surgeon author concluded part result suggest robotic surgery may shorten length stay rate conversion open compared laparoscopy experience mitigating potential difference operating time improving rate intraoperative complication conversion open surgery n march year dr nicole lunardi university texas southwestern along colleague hospital data support intuitive health economics outcome research team reported outcome describing use robotic technology emergency general surgery case published jama surgery analysis used pi cai healthcare database database collect data facility identify adult patient undergoing urgent emergent cholecystectomy colectomy inguinal ventral hernia repair reference emergent procedure described required lifethreatening potentially disabling condition urgent procedure immediate intervention needed prioritized first available million urgent emergent procedure identified study period use roboticassisted surgery procedure experienced fold increase cholecystectomy sixfold increase colectomy fold increase inguinal hernia repair notably increase roboticassisted approach corresponded decrease open approach procedure well decrease laparoscopy cholecystectomy colectomy procedure furthermore propensity score matched analysis demonstrated lower risk conversion open roboticassisted approach compared laparoscopy cholecystectomy procedure lower risk conversion colectomy lower risk inguinal hernia repair lower risk ventral hernia repair lower risk conversion author concluded application robotic surgery emergency general surgery steadily increased past decade especially useful older patient several comorbidities observed cohort study compared laparoscopic surgery robotic surgery appears resulted lower rate conversion open surgery robotic surgery also lead shorter comparable postoperative length stay hospital nevertheless open surgery remains key component emergency general surgery robotic surgery continues increase emergency general surgery barrier implementation need addressed optimized coordinated effort across stakeholder turn financial outlook starting procedure last call forecasted full year procedure growth within range increasing forecast expect full year procedure growth low end range assumes weakness bariatric procedure along challenge china increasing provincial robotic competition delayed tender impacting capital placement therefore procedure growth also assume benefit patient backlog year high end range assume bariatrics continues flat slightly positive growth rate factor china significant impact business addition assume backlog patient would decline throughout year turning gross profit continue expect pro forma gross profit margin within net revenue pro forma gross profit margin reflects impact growth newer product da vinci ion sp impact capital investment come support growth business actual gross profit margin vary quarter quarter depending largely product regional tradein mix impact new product mix turning operating expense holding guidance pro forma operating expense growth continue expect noncash stock compensation expense range million million holding guidance income comprised mostly interest income total million million regard capital expenditure continue estimate range billion billion primarily planned facility construction activity regard income tax change guidance pro forma income tax rate pretax income concludes prepared comment open call question thank question answer operatorthank operator instruction go first question time robbie marcus jp morgan please go ahead robbie marcus jp morgan analyst great congrats nice quarter hoping could touch surprised procedure volume really difficult quarter could walk u view driving obviously gave color procedure really strong number give confidence sustainable raised guidance rest year gary guthart chief executive officer yeah going turn first question jamie thanks marcus jamie go add thought thereafterjamie samath chief financial officer yeah saw particular strength regionally u uk particular also see ous market brian described continuing growth procedure beyond urology first focused cancer procedure colorectal thoracic hysterectomy early stage growth benign international market combination thing think behind performance q kind look input team get feedback customer think kind reflect rest year guidance obviously guidance point high end range something watching carefully robbie marcus jp morgan analyst maybe quick followup sage conference doctor feedback phenomenal da vinci end doctor spoke hoping could give u early feedback heard across field doctor willingness hospital willingness add new system upgrade fleet hearing thanks lotgary guthart chief executive officer yeah term early feedback hearing think hoping term design intent appreciating improvement precision imaging workflow team effort human factor design user interface strong commentary ergonomics think force feedback something new create opportunity really understand clinical implication force application surgery think exciting powerful time think really hard u sitting today predict depth timing replacement cycle excited think folk excited potential product said xi great xi lot clinical indication going supply constraint work launch jamie know anything would like add today jamie samath chief financial officer think got garygary guthart chief executive officer thanks robbie operatorwell go next line larry biegelsen well fargo please go ahead larry biegelsen well fargo security analyst thanks taking question echo robbies congratulation nice quarter two da vinci maybe starting gary supply constraint expect resolved long limited launch last trigger full launch gary guthart chief executive officer yeah thanks larry three thing going u one optimizing supply chain making sure quality want sure go part early part one second thing want incorporate feedback customer want make sure adjusting thing need adjust make sure highly satisfied last thing additional feature content hardware improvement thing planned design team going execute whether software update thing imaging want bring kind threepart set activity think pretty well planned would expect big change plan change future sure talk larry biegelsen well fargo security analyst helpful gary specific new indication da vinci could open help u understand feature da vinci could allow physician new procedure thanks taking question gary guthart chief executive officer yeah first thought bringing system market allow surgeon go deeper existing indication already indication da vinci largely mirror xi indication already think invite new surgeon care team roboticassisted surgery think allows u deepen relationship customer base excited term core capability da vinci really cool thing better imaging right today better get better time precision high performance tracking performance allows really subtle fine surgical motion think really powerful core capability faster workflow open new opportunity people think additional clinical indication pursue evaluating finalized everything yet likely require conversation fda prepared time tell might get little closer work describe settled approach operatorand go next line travis steed bank america please go ahead travis steed bank america merrill lynch analyst wanted ask little bit color strong xi placement capital environment even ahead dv launch sounded like message changed system placement think think system placement could lower choppy mean chance system placement gary guthart chief executive officer jamie jamie samath chief financial officer oh go ahead garygary guthart chief executive officer jamie go ahead take apologiesjamie samath chief financial officer yes think first dynamic trading given limited supply dv placement measured launch focused incremental placement lot trade activity coming dv look left installed base thirdgen xi got system globally u expect trading volume quite bit respect overall system placement know made comment last call generally guide system placement let run model given update procedure guidance certainly acknowledged placement could choppy constrained dv q really see customer pushing back want xi want wait dv since launch obviously march connect conference sage week significant number surgeon executive seen dv put hand acknowledging customer may choose wait enough evidence indication yet see way gotravis steed bank america merrill lynch analyst great maybe gary could spend time kind bigger picture question dv capability brings training able practice edge case helping proctoring curious see impact robotic surgery adoption driving better outcome dv training capability going roll long stuff actually going take gary guthart chief executive officer term raw capability think help care team acquire skill quickly also help case kind think context sensitive help device kind aware share information care team thing whether changing tool setting provides realtime help help guide think really good thing make easier use intuitive hub integration technology start da vinci get better time release software update hardware update start close analytical loop customer seeing case video review video analytics feeding back information phone laptop whatever mean consuming data give analytical loop also help also continue evolve simulation training package online learning help well think going take little bit time think design concept think designer beautiful job think design concept integrating idea making easy care team surgeon follow journey help u final point make lab early experience da vinci look like force reflection help novice new robotics new robotics system surgery acquire skill faster invite surgeon ease journey remains proven done done think encouraging stay tuned think keep asking question data start come pleased share youtravis steed bank america merrill lynch analyst great wait see congratsoperatorok go next line rick wise stifel please go aheadrick wise stifel financial corp analyst good afternoon gary maybe would helpful hear little detail thought couple point maybe headwind bariatrics flat year year sure completely hearing trend getting worse still rate pressure easing appreciate talking guidance talked range given range outcome want make sure understood saying gary guthart chief executive officer yeah let share perspective rick thanks question brian kick talk range think tell see seen continued deceleration flat year year lot opinion field talk think reality nobody really know yet going live together result going dynamic know bariatric surgery well tolerated good option also know people interested pharmaceutical pharmaceutical work long take subset population stop working mean future surgery think range opinion would hang lot confidence yet range brian perhaps touch see bariatric surgery affecting range reiterate wouldbrian king head investor relation sure reiterate low end range assumes weakness bariatric procedure right low end range weakness bariatric procedure high end range assume bariatrics continues flat slightly positive growth rate think gary point dynamic going see play throughout yearrick wise stifel financial corp analyst ok great let turn new incremental feature talked gary sure u call talking doctor hearing variety additional feature quite compelling give u flavor mean first would happy hear could quickly given know today could see feature would assume would enhance value going see year second half likely something next year get supply chain want thank yougary guthart chief executive officer yeah think add capability time imaging thing want thing term software upgrade analytics power thing want term integration much likely later lot making sure supplier feel great got adapting immediate feedback see operatorand go next line adam maeder piper sandler please go ahead adam maeder piper sandler analyst good afternoon thank taking question congrats nice quarter wanted start asking force feedback instrument hoping gary could share little bit color feedback getting clinician thus far launch understand correctly six force feedback instrument used across different common procedure look expand portfolio technology going forward might look like followup thank gary guthart chief executive officer sure getting variety feedback instrument reminder everyone sensitive sensor built distal end body end instrument sterilizable cleanable report back contact force tissue sensitive way goal u surgery long time hard technology really excited bring market hear everything hey getting great result da vinci x xi today limited version haptics really body sensing little something sensing technical sense true getting great result new sense said people quite interested explore take interesting using force sensing instrument sensing whether turn force reflection surgeon hand surgeon feel turn turn still measure feeling experience x xi find turn amount force apply surgery tissue decrease force reflection hand big question clinical value implication patient outcome procedure technique going go explore help exploration talking future could happen suspect believe personal opinion type procedure type patient lower force applied tissue surgery going clinically meaningful go prove think quite interesting technology sophisticated manufacturing partner learning make scale good yield robust worthy endeavor easy going focus make sure get want want make sure robust highyield product want extend life help economics customer economics first focus six instrument going look jamie whether six number right think certainly time opportunity extend instrument first set six one thought right six right number jamiejamie samath chief financial officer combination graspers needle driver instrument used common task dissection retraction suturinggary guthart chief executive officer thanks adamoperatorwell go next line drew ranieri morgan stanley please go ahead drew ranieri morgan stanley analyst thank taking question maybe sp moment indication expansion europe talk bit gary hearing surgeon today crsa conference november rome could pretty important getting broader adoption european surgeon inform could approach u market broader indication followup gary guthart chief executive officer yeah yeah actually europe last couple week talking sp surgeon think early uptake early excitement quite palpable broad indication know korea japan seen nice uptake adoption good study good clinical study think surgeon building learning adapting see rest world getting excited encouraged deep go still early day europe see starting see fairly long case study thing like colorectal surgery coming asia place submitted jamie mentioned additional indication united state another one coming ide trial ongoing natural experiment see occurs know experiment korea worked well process japan early experience broad indication europe help u generate data accelerate additional indication time u say think remains build sp encouraged build drew ranieri morgan stanley analyst thank maybe jamie jamie could talk commentary lower pricing china quarter talk little bit maybe put context temporary permanent come overall competitive situation china would great thank jamie samath chief financial officer yeah primarily function competitive environment described domestic robotic player actually given last year qualified domestically manufactured xi actually segmentation domestically manufactured product imported product domestic product give u opportunity participate tender require locally produced system also allows u segment price primary impact china pricing really competition kind see theme broadly med tech player term impact vbp apply case kind macro theme pricing pressure operatorand go next line matt miksic barclays please go ahead matt miksic barclays analyst hey thanks much taking question congrats really strong quarter tough comp couple followup could couple thing mentioned gary last answer around force feedback sort clinical impact optimizing reducing force used surgery kind buzzing around sage quite bit year session wondering appreciate always data talked prepared remark recent clinical data wondering far going see clinical reference like study around use force feedback versus also maybe efficiency driven lot doc talking smoother operating arm able get case faster year six month two year dv research like appreciate taking questiongary guthart chief executive officer yeah good question thank approximate specific take error bar think going see force feedback study going progression see narrow series singleinstitution study come first kind directional talk seeing see little bit kind thing come next month next period next couple year see multiple center trial comparing little structured way think predict path journey think something going see narrower input start broader input next year prospective study start report next year think build think going powerful build end think regard efficiency hearing anecdotal report already surgeon autonomy feature da vinci ability control field control equipment ancillary equipment room really positive reporting efficiency already think realworld evidence going powerful efficiency side think kind thing people benchmark case also data collection capability intuitive hub intuitive app allowed measure quickly think see realworld evidence build coming month quarter exciting usmatt miksic barclays analyst great thank youoperatorwell go next line brandon vazquez william blair please go aheadbrandon vazquez william blair analyst thanks taking question want focus ion real quick nice rebound quarter thereafter supply last quarter curious see little bit catchup even number getting bigger still putting really strong growth curious seeing growth new account existing utilization sustainable think gary guthart chief executive officer jamie take onejamie samath chief financial officer yeah would say partial recovery quarter completely resolved catheter supply vision probe still little bit backlog term number system pending kind stabilization supply respect placing system actually blend existing account new account still number opportunity call greenfield account focus sale team brandon vazquez william blair analyst ok one quick followup maybe surgical side utilization growth appreciate tough comp kind normalizing think usually use utilization growth indication system placement implies certain procedure growth well talk u little bit kind think historical average utilization growth quarter might mean key moving piece next couple quarter thanks gary guthart chief executive officer start jamie samath chief financial officer go ahead gary gary guthart chief executive officer jump jamie take think prepared remark said nice capital placement year bolus postcovid come back q think uncertainty part really going inpatient volume look like next quarter word patient census come right think indicator capacity depending patient census look like determine high end low end utilization growth term many procedure people want put system sorry jamie go ahead might discus modeling therejamie samath chief financial officer would say look q utilization extended period look cagr versus yearoveryear comparison see start normal range think yearago quarter number institution actually set sprint respect ability treat patient think elevated level utilization growth particularly sustainable look forward rest year would expect level utilization growth let u say closer longterm average still patient backlog benefit yearago quarter even q q perfectly matched think room normalization timeoperatorand go next question line jayson bedford raymond james please go ahead jayson bedford raymond james analyst good afternoon thanks taking question maybe ion china obviously large opportunity couple question apologize missed ion fall within existing robotics quota ion mentioned clearance first step talk step commercialization associated timing step thanksjamie samath chief financial officer yeah work put ion point actually available sell take u time expecting commercialization really back half china market like many case launch new product market progressively kind build infrastructure term training capability engage customer would say back half start see potential ion placement chinagary guthart chief executive officer issue competing quota jamie jamie samath chief financial officer sorry yes understanding quota given pricejayson bedford raymond james analyst thank yougary guthart chief executive officer jayson one followup wrap usjayson bedford raymond james analyst fine thank gary guthart chief executive officer ok last question closing continue believe substantial durable opportunity fundamentally improve surgery acute intervention team continue work closely hospital physician care team pursuit customer termed quadruple aim better predictable patient outcome better experience patient better experience care team ultimately lower total cost care believe value creation surgery acute care foundationally human flow respect understanding patient care team need environment intuitive envision future care le invasive profoundly better disease identified earlier treated quickly patient get back matter thank support extraordinary journey look forward talking three monthsoperatoroperator instruction duration minutescall participantsbrian king head investor relationsgary guthart chief executive officerjamie samath chief financial officerrobbie marcus jp morgan analystlarry biegelsen well fargo security analysttravis steed bank america merrill lynch analystrick wise stifel financial corp analystadam maeder piper sandler analystdrew ranieri morgan stanley analystmatt miksic barclays analystbrandon vazquez william blair analystjayson bedford raymond james analyst isrg analysis earnings call transcript article transcript conference call produced motley fool strive foolish best may error omission inaccuracy transcript article motley fool assume responsibility use content strongly encourage research including listening call reading company sec filing please see term condition additional detail including obligatory capitalized disclaimer liabilitythe motley fool position recommends intuitive surgical motley fool disclosure policy